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BACKGROUND: More than 20 years ago, it was hypothesized that exposure to prenatal and early postnatal environmental xenobiotics
with the potential to disrupt endogenous hormone signaling might be on the causal path to cryptorchidism, hypospadias, low sperm count
and testicular cancer. Several consensus statements and narrative reviews in recent years have divided the scientiﬁc community and have
elicited a call for systematic transparent reviews. We aimed to ﬁll this gap in knowledge in the ﬁeld of male reproductive disorders.
OBJECTIVE AND RATIONALE: The aim of this study was to systematically synthesize published data on the risk of cryptorchidism,
hypospadias, low sperm counts and testicular cancer following in utero or infant exposure to chemicals that have been included on the
European Commission’s list of Category 1 endocrine disrupting chemicals deﬁned as having documented adverse effects due to endocrine
disruption in at least one intact organism.
SEARCH METHODS: A systematic literature search for original peer reviewed papers was performed in the databases PubMed and
Embase to identify epidemiological studies reporting associations between the outcomes of interest and exposures documented by bio-
chemical analyses of biospecimens including maternal blood or urine, placenta or fat tissue as well as amnion ﬂuid, cord blood or breast
milk; this was followed by meta-analysis of quantitative data.
OUTCOMES: The literature search resulted in 1314 references among which we identiﬁed 33 papers(28 study populations) fulﬁlling the
eligibility criteria. These provided 85 risk estimates of links between persistent organic pollutants and rapidly metabolized compounds
(phthalates and Bisphenol A) and male reproductive disorders. The overall odds ratio (OR) across all exposures and outcomes was 1.11
(95% CI 0.91–1.35). When assessing four speciﬁc chemical subgroups with sufﬁcient data for meta-analysis for all outcomes, we found that
exposure to one of the four compounds, p,p′-DDE, was related to an elevated risk: OR 1.35 (95% CI 1.04–1.74). The data did not indi-
cate that this increased risk was driven by any speciﬁc disorder.
WIDER IMPLICATIONS: The current epidemiological evidence is compatible with a small increased risk of male reproductive disorders
following prenatal and postnatal exposure to some persistent environmental chemicals classiﬁed as endocrine disruptors but the evidence
is limited. Future epidemiological studies may change the weight of the evidence in either direction. No evidence of distortion due to publi-
cation bias was found, but exposure–response relationships are not evident. There are insufﬁcient data on rapidly metabolized endocrine
disruptors and on speciﬁc exposure–outcome relations. A particular data gap is evident with respect to delayed effects on semen quality
and testicular cancer. Although high quality epidemiological studies are still sparse, future systematic and transparent reviews may provide
pieces of evidence contributing to the narrative and weight of the evidence assessments in the ﬁeld.
Key words: cryptorchidism / endocrine disruption / hypospadias / infertility / prenatal exposure / sperm count / testicular cancer /
xenobiotics
Introduction
As early as 1979, Henderson et al. hypothesized that a relative excess
of estrogen, in particular at the time of testicle differentiation, is a major
risk factor for testicular cancer (Henderson et al., 1979). Fourteen years
later, Sharpe and Skakkebaek proposed that not only testicular cancer
but also other male reproductive disorders such as cryptorchidism,
hypospadias and low sperm counts may share a common fetal origin
and that environmental exposure to chemicals with actions mimicking
estrogens might play a pivotal role (Sharpe and Skakkebaek, 1993). The
underlying mechanisms were thought to include increased negative
feedback on the fetal pituitary resulting in reduced levels of
gonadotrophins leading to disruption of normal development of the
male fetal gonad during the late phase of the ﬁrst trimester of pregnancy
(Sharpe and Skakkebaek, 1993). This so-called estrogen hypothesis has
been scrutinized by a large number of studies addressing the risk of
male reproductive disorders in boys who, during pregnancy, were
exposed to high or low levels of estrogens because of twin pregnancy,
ﬁrst parity, preeclampsia, hyperemesis or intended or incidental treat-
ment with synthetic hormones during ﬁrst trimester. Three literature
reviews provide no support for the estrogen hypothesis except that
testicular cancer seems related to high prenatal estrogen exposure
(Sever et al., 1997; Storgaard et al., 2006; Martin et al., 2008). In par-
ticular, it is notable that prenatal exposure to the highly potent synthetic
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estrogen diethylstilbestrol is only associated with low sperm count at
high doses (Gill et al., 1979; Leary et al., 1984). Subsequently a cap-
acious amount of experimental research has indicated that adverse
health effects, including male reproductive disorders, may be related to
endocrine disruption of fetal development through xenobiotic inter-
action with steroid hormone receptors or through interference with
the synthesis, secretion, transport, metabolism or degradation of nat-
ural hormones (European workshop on the impact of endocrine disrup-
ters on human health and wildlife. Report of proceedings from a
workshop held in Weybridge, UK, 2–4 December 1996; World Health
Organisation (WHO) and United Nations Environment Program
(UNEP), 2012). This broader endocrine disruption hypothesis with
focus on environmental pollutants has gained tremendous public and
scientiﬁc attention in the USA and the European Union over the past
15 years. Numerous narrative reviews and consensus statements have
discussed supporting and contradicting evidence based on data of secu-
lar trends of male reproductive health outcomes, wildlife impact and
exposure levels in various populations, in addition to the large body of
in vitro and in vivo experimental data (European workshop on the impact
of endocrine disrupters on human health and wildlife. Report of pro-
ceedings from a workshop held in Weybridge, UK, 2–4 December
1996; Bergman et al., 2013; Cantonwine et al., 2014; Diamanti-
Kandarakis et al., 2009; Lamb et al., 2014; Nohynek et al., 2013;
Sharpe, 2001; Sharpe and Irvine, 2004; Skakkebaek et al., 2001;
Takahashi et al., 2004; Toppari et al., 2010; Vandenberg et al., 2012;
World Health Organisation (WHO) and International Programme on
Chemical Safety (IPCS), 2002; World Health Organisation (WHO) and
United Nations Environment Program (UNEP), 2012). It is particularly
noteworthy that biomonitoring data from all over the world provide
unequivocal documentation of human exposure to a range of xeno-
biotic substances including persistent compounds (Govarts et al., 2012;
Lenters et al., 2013; Gyalpo et al., 2016; Hung et al., 2016; Liu et al.,
2016; Magulova and Priceputu, 2016) as well as rapidly metabolized
and excreted compounds that reach steady state concentrations in
human blood and tissues because of continuous exposure (Arbuckle
et al., 2016; Zhang et al., 2016). These xenobiotic compounds have
been released into the environment intentionally via the widespread
application of pesticides or unintentionally by either degradation of
industrial products and building materials or by leakage of packing mate-
rials into food items (Nam et al., 2010). New exposure pathways are
described regularly. For instance, it has recently been reported that
semi-volatile polychlorinated biphenyls (PCBs) represent an important
inhalation exposure pathway for residents living in PCB contaminated
homes containing PCB in calking material, paints and sealant used >40
years ago (Frederiksen et al., 2012; Meyer et al., 2013). Exposure by
inhalation and possibly through the skin may more than double the PCB
body burden in individuals exposed at the residence or at school
(Meyer et al., 2013). Considering the mounting evidence that numerous
of these environmental xenobiotics exhibit endocrine activity in in vitro
and in vivo assays, there is basis for substantial concern regarding the
potential health effects in humans (Gabrielsen and Tanrikut, 2016;
McLachlan, 2016; Trasande et al., 2016), even if alarming reports on,
for instance, declining sperm counts are circumstantial or not corrobo-
rated (Bonde et al., 2011) and the best evidence we have is reassuring
(Jorgensen et al., 2012).
However, the epidemiological data on the adverse health effects are
sparse, particularly regarding links with prenatal and postnatal exposure,
and there is presently no consensus. In 2012, a Global Assessment of
the State-of-the-Science of Endocrine Disrupters commissioned by the
World Health Organization and United Nations Environment Program
concluded that the direct evidence for endocrine disrupting effects with
adverse health effects because of exposure to xenobiotic substances is
limited in humans, but emphasized the need for continuous attention
(European workshop on the impact of endocrine disrupters on human
health and wildlife. Report of proceedings from a workshop held in
Weybridge, UK, 2–4 December 1996; World Health Organisation
(WHO) and United Nations Environment Program (UNEP), 2012). As
several epidemiological studies addressing this issue have been pub-
lished over the past 10 years, a systematic evaluation of the epidemio-
logical evidence on effects of environmental endocrine disrupting
xenobiotics including quantitative meta-analyses of data, where feasible,
has now become timely (Beronius and Vandenberg, 2015).
Therefore, the objective of this review was to identify and evaluate
the epidemiological evidence linking adverse reproductive health disor-
ders with in utero or early postnatal exposure to xenobiotic endocrine
disrupting compounds. The key eligibility criteria are documentation of
exposure contrast by chemical measurements of the compounds in
maternal blood or other biospecimens indicative of fetal or infant expos-
ure. Speciﬁcally, we address the following four hypotheses on the risk of
adverse male reproductive outcomes following prenatal and postnatal
environmental exposure to industrial chemicals classiﬁed as endocrine
disrupting substances (McCarthy, 2011): (i) that all compounds regard-
less of speciﬁc endocrine disrupting properties carry a risk of reproduct-
ive disorders considered as one outcome entity; (ii) that speciﬁc
compounds are heterogeneous with respect to reproductive disorders
considered as one entity; (iii) that all compounds regardless of speciﬁc
endocrine disrupting properties carry a risk for speciﬁc outcomes; and
(iv) that speciﬁc compounds carry a risk for speciﬁc outcomes.
Methods
The review was conducted and reported in accordance with the MOOSE
guidelines for Meta-analyses and Systematic reviews of Observational
Studies (Stroup et al., 2000).
Protocol and registration
A review protocol was registered at PROSPERO.org with registration
number CRD4201603742 prior to initiation of the review process, on 12
April 2016 with amendments on 12 May 2016 (CRD420160374X). The
amendments speciﬁed the four main hypotheses, provided details on sen-
sitivity analyses and discarded the initial idea to analyze data according to
estrogenic or anti-androgenic activity of measured compounds which
proved non-feasible. The protocol was updated before the review pro-
cess and data analysis were initiated.
Information sources
The databases PubMed and Embase were used as they cover the vast
majority of relevant journals for the subject.
Eligibility criteria
We conducted a systematic search of original peer-reviewed original
papers in English published between 1966 and 12 April 2016 to identify
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journal articles providing quantitative data on the association between
xenobiotic endocrine disrupting chemicals and male reproductive disor-
ders in humans. The complete search speciﬁcation is provided in the
online Supplementary Table 1. Eligibility criteria for inclusion in the sys-
tematic review were as follows.
(1) Exposures: Chemicals that by the European Commission are classiﬁed
as Category 1 endocrine disruptors with high concern in terms of
human or wildlife exposure (McCarthy, 2011). Category 1 compounds
are deﬁned as chemicals where at least one study has shown endocrine
effects in an intact organism. The EU report lists 60 Category 1 sub-
stances (29 chemical groups) that are highly persistent or have high
current production volume (McCarthy, 2011). In addition we include
the polyﬂuorinated chemicals, a group of ubiquitous biopersistent
emerging endocrine disruptors (White et al., 2011) that are receiving
increasing attention. Table I lists the speciﬁc chemical substances with
abbreviations that are referenced in the text and in Tables II–VII.
(2) Outcomes: Cryptorchidism (one or both testicles undescended)
ascertained at birth or during childhood, hypospadias, testicular can-
cer regardless of histological subgroup, and sperm count (number of
spermatozoa per volume or mass unit of seminal ﬂuid).
(3) Exposure to speciﬁc chemicals in utero or in the ﬁrst year of life (post-
natal exposure) documented by measurements in biological
specimens (maternal blood or urine, placenta or fat tissue as well as
amnion ﬂuid, cord blood or breast milk). In addition serum concen-
trations in adult life as proxies for fetal or early life exposure were
also included for testicular cancer.
(4) Outcome ascertainment by medical standardized examination or
antecedent medical records or reporting to health registries.
(5) Risk estimates (rate risk [RR], OR, hazard ratio [HR]) for an outcome
according to higher versus lower levels of prenatal and postnatal
exposure deﬁned by exposure contrasts within the given study.
Studies reporting alternative measures of association such as differ-
ence in mean values of exposure levels in cases and controls were
also included, and the authors were contacted to get risk estimates
(Hosie et al., 2000; Damgaard et al., 2006; Main et al., 2007;
Choi et al., 2012; Fenichel et al., 2012; Komarowska et al., 2015;
Virtanen et al., 2012). Several authors responded positively but
reanalysis of the original data could not be accomplished within the
given time-frame and the studies were therefore not included in the
present review.
Criteria for exclusion of studies were as follows:
(1) In vitro and in vivo experimental studies.
(2) Studies addressing mechanisms and other outcomes related to endo-
crine disruption, for example, effects on sexual hormone levels in tis-
sues and measures of semen quality other than sperm concentration.
(3) Studies based upon chemical analysis of exposure after puberty
except studies of testicular cancer.
(4) Studies repeating risk estimates reported in previous publications for
example, studies addressing risk according to gene polymorphisms
for substances, where risk estimates for the entire population were
provided earlier.
(5) Ecological studies with exposure information at the population level
rather than at the individual level.
Search and study selection
We combined medical subject headings and generic terms for the expo-
sures and outcomes (Supplementary Table 1) and obtained in total 1314
hits after removal of duplicates. Two authors (JPB and EVB) sifted titles
and abstracts independently to assess eligibility and retrieved 110 papers
for full text reading. Among these, several reports failed to provide quan-
titative data on exposure levels and others were excluded for other rea-
sons detailed in Supplementary Table 2. Hand searches of the
bibliographies of retrieved primary reports and reviews did not capture
additional papers.
We selected 19 epidemiological studies (21 papers) that provided at
least one risk estimate for a male reproductive disorder according to at
least one measured xenobiotic classiﬁed as an endocrine disruptor.
Moreover, nine studies (12 papers) that compared average exposure
levels in cases and referents without providing risk estimates were
included. Thus, the ﬁnal database comprised 33 papers included for
qualitative systematic analysis and 21 papers included for quantitative
meta-analysis. No attempt was made to retrieve papers from the
unpublished literature. The steps in the literature search are displayed
in Fig. 1.
Data extraction
Descriptive information (Tables II–V) was recorded from each publication
using a standardized form constructed prior to the collection process.
Table I List of speciﬁc chemical substances with
abbreviations.
Bisphenol A 4,4′-(Propan-2,2-diyl)diphenol
mBP Mono-n-butyl-phthalate
Chlordane
mix
cis-heptachlordane, cis-chlordane, ocychlordane, trans-
nonachlordane, cis-nonachlordane
DBP Di-n-butyl-phthalate
DDE 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene
o,p′-DDT 1,1,1-Tricholoro-2-(p-chlororphenyl)-2-(o-chlorophenyl)
ethane
p,p′-DDT 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane
DEHP Di-(2-ethylhexyl)phthalate
Dieldrin Derivate of norbornadiene and
hexachlorocyclopentadiene
HCB Hexachlorobenzene
HCE Heptachlor epoxide
HCCH b-Hexachlorocyclohexane
MEHP Mono-(2-ethylhexyl)phthalate
5cx-MEPP Di(2-ethylhexyl)phthalate [metabolite of DEHP]
7cx-
MMeHP
Mono(4-ethyl-7-carboxylheptyl)phthalate [metabolite of
DiNP]
Mirex Dimerization derivate of hexachlorocyclopentadiene
n-NP n-Nonylphenol
t-OP t-Octylphenol
PBB Polybrominated biphenyl
PBDE Polybrominated diphenyl ether
PCB Polychlorinated biphenyl
PCDD/Fs Polychlorinated dibenzo-p-dioxins/furans
PFOS Perﬂuorooctane sulfonic acid
PFOA Perﬂuorooctanoic acid
TCDD 2,3,7,8-Tetrachlorodibenzo-p-dioxin
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Table II Characteristics and risk estimates for 10 case-referent studies (18 risk estimates) addressing the risk of cryptorchidism following prenatal and
postnatal exposure to endocrine disrupting chemicals.
Reference Location Study population N Cases/
referents
Exposure medium Exposure contrast Substance OR 95% CI CRa Biasb
Longnecker et al.
(2002)
USA (12 centers) Collaborative Perinatal Project 219/552 Third trimester serum Highest versus lowest quintiles p,p′-DDE 1.30 0.70–2.24 9 0
Pierik et al. (2007) USA (12 centers) Collaborative Perinatal Project 219/564 Third trimester serum 75–90 percentile versus 0–10
percentile
b-HCCH 2.08 1.08–4.01 9 0
HCE 0.82 0.41–1.65
HCB 0.85 0.52–1.40
McGlynn et al.
(2009a)
USA (12 centers) Collaborative Perinatal Project 230/593 Third trimester serum Highest quartile versus lowest PCB (sum of 11
congeners)
1.41 0.90–2.20 8 0
Trabert et al. (2012) USA (12 centers) Collaborative Perinatal Project 217/557 Third trimester serum Highest quartile versus lowest trans-nonachlor 1.22 0.70–2.12 9 0
Oxychlordane 0.95 0.55–1.64
Bhatia et al. (2005) USA, San Francisco Child Health and Development
Study
75/283 Maternal serum Highest versus lowest quartile p,p′- DDT 1.01 0.44–2.28 9 1
p,p′- DDE 1.34 0.51–3.48
Brucker-Davis et al.
(2008)
France, Nice Newborns at maternity clinics in
Nice and Grasse.
56/69 Colostrum Highest versus lowest. Three
categories
p,p′-DDE 2.16 0.94–4.98 7 1
PCB (seven
congeners)
2.74 1.15–6.53
mBP 2.13 0.66–6.83
Small et al. (2009) USA, Michigan Michigan Long-term PBB Study 9/464 Maternal serum Highest versus lowest (<LOD).
Three categories
PBB-153 (Includes
hypospadias)
0.50 0.10–4.70 4 1
Vesterholm et al.
(2014)
Denmark and Finland Danish–Finnish prospective Birth
Cohort Study
107/108 Cord blood Highest tertile versus lowest PFOS 0.83 0.39–1.79 9 0
PFOA 0.46 0.20–1.20 9 0
Jensen et al. (2015) Denmark Pregnancy screening registry,
Serum Institute
270/300 Second trimester
amnion ﬂuid
Highest tertile versus lowest 5cx-MEPP 0.90 0.57–1.41 9 1
7cx-MMeHP 1.28 0.80–2.01
Toft et al. (2016) Denmark Pregnancy screening registry,
Serum Institute
270/300 Second trimester
amnion ﬂuid
Highest tertile versus lowest PFOS 1.01 0.66–1.53 9 1
aCR: completeness of reporting on a scale from 0 (low completeness) to 11 (high completeness).
bBias and confounding: 1 = higher risk of bias, 0 = lower risk of bias.
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Table III Characteristics of 10 case-referent studies (21 risk estimates) addressing the risk of hypospadias following prenatal and postnatal exposure to
endocrine disrupting chemicals.
Reference Location Study population N Cases/
Referents
Exposure
medium
Exposure contrast Substance OR 95% CI Meta-
analysis
CRa Biasb
Longnecker et al. (2002) USA (12
centers)
Collaborative Perinatal Project 199/552 Third trimester
serum
Highest versus lowest quintiles p,p′-DDE 1.2 0.60–2.40 Yes 8 0
McGlynn et al. (2009a) USA (12
centers)
Collaborative Perinatal Project 201/593 Third trimester
serum
Highest versus lowest quartile PCB (sum of 11
congeners)
1.69 1.06–2.68 Yes 8 1
Trabert et al. (2012) USA (12
centers)
Collaborative Perinatal Project 197/557 Third trimester
serum
Highest quartile versus lowest trans-nonachlor 1.08 0.62–1.89 Yes 9 0
Oxychlordane 1.24 0.69–2.22 Yes 9
Bhatia et al. (2005) USA, San
Francisco
Child Health and Development
Study
66/283 Maternal serum Highest versus lowest quartile p,p′-DDT 0.79 0.33–1.89 Yes 9 0
p,p′-DDE 1.18 0.46–3.02 Yes 9 0
Small et al. (2009) USA,
Michigan
Michigan Long-term PBB Study 14/431 Maternal serum Highest versus lowest (<LOD).
3 categories
PBB-153 (includes
cryptorchidism)
0.71 0.1–3.8 Yes 4 1
Carmichael et al. (2010) USA,
California
Pregnant women participating
in a screening program
20/28 Maternal serum OR for a 1–10 ng/g lipid
change in the analyte
PBDE-100 1.02 0.74–1.35 Yes 5 1
PCB-153 0.84 0.30–2.46 Yes 5 1
HCB 0.95 0.79–1.13 Yes 5 1
p,p′-DDT 1 0.99–1.01 No 5 1
p,p′-DDE 1 0.95–1.00 No 5 1
Giordano et al. (2010) Italy, Rome Children enrolled at two
Hospitals
37/21 Mid pregnancy
serum
Above versus below median p,p′-DDE 1.18 0.47–6.91 Yes 5 1
HCB 5.5 1.25–24.31 Yes 5 1
PCB (four congeners) 1.89 0.51–6.93 Yes 5 1
Rignell-Hydbom et al.
(2012)
Sweden Southen Sweden maternity
cohort
237/237 Early pregnancy
serum
Highest quartile versus lowest PCB-153 0.60 0.30–1.19 Yes 10 0
p,p′-DDE 1.68 0.92–3.08 Yes 10 0
HCB 1.59 0.86–2.93 Yes 10 0
Jensen et al. (2015) Denmark Pregnancy screening registry,
Serum Institute
75/300 Second trimester
amnion ﬂuid
Highest tertile versus lowest 5cx-MEPP 0.89 0.44–1.80 Yes 9 1
7cx-MMeHP 1.69 0.78–3.67 Yes 9 1
Toft et al. (2016) Denmark Pregnancy screening registry,
Serum Institute
75/300 Second trimester
amnion ﬂuid
Highest tertile versus lowest PFOS 0.69 0.35–1.38 Yes 9 1
aCR: completeness of reporting on a scale from 0 (low completeness) to 11 (high completeness).
bBias and confounding: 1 = higher risk of bias, 0 = lower risk of bias.
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Table IV Characteristics of six case-referent studies (36 risk estimates) addressing the risk of testicular cancer following exposure to endocrine disrupting
chemicals.
Reference Location Study population N Cases/
referents
Exposure medium Exposure contrast Substance RR 95% CI CRa Biasb
Hardell et al.
(2003)
Sweden Patients referred to hospital
departments in 5 Swedish
cities
58/61 Blood, diagnosed men Above versus below
median in referents
PCB (sum of 38
congeners)
1.10 0.50–2.60 9 1
HCB 1.70 0.80–3.60 9 1
p,p′-DDE 1.70 0.80–3.70 9 1
Chlordane 1.30 0.60–2.80 9 1
44/45 Blood, mothers at time of sons diagnosis Above versus below
median in referents
PCB (sum of 38
congeners)
3.80 1.40–10.0 9 1
HCB 4.40 1.70–12.0 9 1
p,p′-DDE 1.30 0.50–3.00 9 1
Chlordane 1.90 0.70–5.00 9 1
Hardell et al.
(2006)
Sweden Patients referred to hospital
departments in 5 Swedish
cities
44/45 Blood, mothers at time of sons diagnosis Above versus below
median in referents
PBDE 47, 99, 153 2.50 1.02–6.00 9 1
Biggs et al.
(2008)
USA,
Washing-
ton State
The general population 246/630 Blood, men when diagnosed Above 85th percentile
versus below 50th
percentile in referents
p,p′-DDT 1.17 0.68–2.00 9 1
o,p′-DDT 1.30 0.67–2.53 9 1
Chlordane (six
substances)
0.93 0.51–1.68 9 1
HCB 0.85 0.37–1.96 9 1
Mirex 0.87 0.50–1.53 9 1
Dieldrin 0.79 0.44–1.41 9 1
DDE 0.61 0.32–1.14 9 1
McGlynn
et al. (2008)
USA US servicemen who had
donated serum between 1987
and 2002
739/915 Serum, adult males (bio-banked, (mean storage
time 14.2 years))
Highest quartile versus
lowest
DDT 1.13 0.71–1.82 11 0
DDE 1.71 1.23–2.38 11 0
Chlordane 1.51 1.09–2.10 11 0
Mirex 1.24 0.90–1.74 11 0
HCCH 0.90 0.65–1.24 11 0
McGlynn
et al.
(2009b)
USA US servicemen who had
donated serum between 1987
and 2002
736/913 Serum, adult males (bio-banked, (mean storage
time 14.2 years))
Highest quartile versus
lowest
PCB (sum of 11
congeners)
0.61 0.43–0.86 11 0
Purdue et al.
(2009)
Norway Citizens with serum stored in
the Norwegian cancer
Registry
49/51 Serum, men (pre-diagnostic serum samples
from between 1972 and 1978 in the Norwegian
Janus Serum Bank)
Highest tertile versus
lowest
o,p′-DDT 1.40 0.40–4.50 7 1
p,p′-DDT 2.10 0.60–7.20 7 1
p,p′-DDE 2.20 0.70–6.50 7 1
Chlordane 2.30 0.60–7.20 7 1
Total PCB 1.30 0.50–3.80 7 1
Dieldrin 2.10 0.50–9.50 7 1
HCB 2.90 0.50–15.20 7 1
β-HCCH 1.80 0.50–6.10 7 1
λ-HCCH 1.10 0.20–5.00 7 1
Mirex 1.20 0.40–3.00 7 1
Cohn et al.
(2010)
The Child Health and
Development Studies
15/45 Early postpartum maternal serum p,p′-DDT 0.70 0.26–1.64 8 1
p,p′-DDE 0.19 0.04–0.62 8
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The standardized data extraction form is provided in Supplementary
Table 3. Risk estimates with 95% CI were extracted for each measured
compound and outcome. Sperm concentration (sperm count) was taken
as the most relevant and robust measure of semen quality despite the
substantial within- and between- individual variation (Schrader et al.,
1988), while other indicators such as motility and morphology were
ignored. When risk estimates were available for groups of chemicals, for
example, PCB and PBDE congeners and phthalate metabolites, we used
the summed risk estimate, if provided. Otherwise, we selected indicator
congeners such as PCB-153 and PBDE-100 reﬂecting levels of all respect-
ive congeners. When risk according to several levels of exposure was
reported, the highest level versus the reference category was chosen. In
one study, the highest level was greater than the 90th percentile (Pierik
et al., 2004); therefore, we used the next highest exposure category in
that study to allow for theoretical inverse relationships. If the relevant
relative risks were not reported but data were available, the authors of
this paper computed risk estimates and CIs.
Quality assessment
Reporting
Each publication was evaluated for completeness of reporting of the fol-
lowing 11 study characteristics modiﬁed after Bonzini et al., (2007): (i)
study design, (ii) sampling frame and procedures, (iii) inclusion and exclu-
sion criteria, (iv) population characteristics of exposed/unexposed or
cases/referents, (v) response rates reported or given implicitly, (vi) meth-
ods for exposure measurements (reference to method for chemical ana-
lysis or detailed description), (vii) criteria for outcome ascertainment,
(viii) external quality assurance program of biochemical analyses (certiﬁed
laboratory and/or participating in analyses of spiked samples from other
laboratories), (ix) detection level, recovery and precision (CV) provided
on all issues, (x) statistical analysis, and (xi) reporting of exposure–
response relationship (Supplementary Table 3).
We evaluated whether each of these study characteristics were
described or not and assigned a value of one if the criterion was fulﬁlled
and zero if not. Giving equal weight to each of the 11 items, we consid-
ered completeness of reporting as sufﬁcient if the sum of the 0/1 scores
for each paper was ≥8 (Bonzini et al., 2007). Completeness of reporting
is not a direct measure of quality but high completeness is needed for
adequate evaluation of bias and confounding.
Bias and confounding
The decision to limit the review to observational epidemiological studies
applying biological monitoring for exposure assessment is considered of
major importance to counteract biased ﬁndings because of differential
recall of exposure often introduced by self-reports or interview informa-
tion. For each study, other sources of bias were evaluated against a pre-
deﬁned list of seven potential sources of bias and confounding adapted
from validated checklists in order to ﬁt the type of studies and research
questions addressed in this review (Shamliyan et al., 2010); these are as
follows:
(1) Reporting of tested hypotheses: Many studies perform multiple
comparisons because numerous chemical compounds have been
measured. A high risk of bias towards inﬂated risk estimates is likely
if risk estimates are selectively reported compared to objectives or
available data.
(2) Sample size justiﬁcation (power calculations and/or addressing sam-
ple size in discussion): Small numbers of cases and/or exposed may
increase the risk of false negative reporting and thus cause bias
towards the null.
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Table V Studies reporting associations between prenatal and postnatal exposure and cryptorchidism or hypospadias without risk estimates (not eligible for
meta-analysis).
Reference Location Study
population
Study
design
N
population
Outcome Bio-
specimen
Measured
xenobiotics
Results CRa Biasb
Hosie et al.
(2000)
Germany Chilldren
undergoing
surgery at one
hospital
Cross-
sectional
18/30 Cryptochidism Fat
samples
26 persistent
organochlorine
pesticides and PCBs.
Median values of 21 among 26 chemicals were higher in cases
and two compunds reached statistical signiﬁcance (HCB and
HCE)
3 1
Damgaard
et al. (2006)
Denmark/
Finland
Danish–Finnish
prospective Birth
Cohort Study
Case-
referent
62/68 Cryptochidism Breast milk 27 biopersistent
POPs
Median values of 14 among 27 chemicals were higher in cases.
No single compound signiﬁcantly elevated. Monte Carlo
analysis of median values indicated higher levels in cases when
the eight compounds with the highest was analysed (P = 0.03)
9 0
Main et al.
(2007)
Denmark/
Finland
Danish–Finnish
prospective Birth
Cohort Study
Case-
referent
95/185
placenta
samples, 62/
68 milk
samples
Cryptochidism Placenta
tissue,
breast milk
14 PBDEs Placenta: no difference between cases and controls for
individual congeners or sum of 14 congeners
9 0
Breast milk: no difference between cases and controls for sum
of 14 PBDE congeners, while seven individual congenres were
signiﬁcantly higher in cases
Virtanen et al.
(2012)
Denmark/
Finland
Danish–Finnish
prospective Birth
Cohort Study
Case-
referent
95/185
placenta
samples,
Cryptochidism Serum 17 TCDDs and
PCDD⁄ Fs) and 37
PCBs
No signiﬁcant difference between cases and controls with
respect to sum of 37 PCBs, PCDD or dioxin equivalents
9 0
Shekharyadav
et al. (2011)
Northern
India
Children with
hypospadias and
age-matched
control children
Case-
referent
80/120 Hypospadias Serum Three HCH isomers,
aldrin, dieldrin, endo
I, endo II, p,p′-DDT,
p,p,-DDE
Higher serum concentrations of all nine pesticides in cases, b-
hexachlorohexane (HCH), g-HCH, and p,p′-dichlorodiphenyl
-dichloroethylene (p,p′-DDE) signiﬁcantly higher
5 1
Choi et al.
(2012)
Republic
of Chorea
No data Cross-
sectional
80/80 Hypospadias Urine
Serum
DEHP, DBP, MEHP,
MBP, PA, n-NP and
t-OP
In urine ﬁve of eight substances higher in cases, in serum three
substances higher, inconsistent with respect to DEHP
(contamination?)
2 1
Fenichel et al.
(2012)
Southern
France
French studies on
cryptorchidism in
Nice and Grasse
Case-
referent
46/106 Cryptochidism Cord
blood
Bisphenol A Mean unconjugated Bisphenol A marginally higher in cases but
not signiﬁcant (P = 0.38)
6 1
Komarowska
et al. (2015)
Poland Children 0–4
years admitted to
paediatric
department
Case-
referent
98/57 Cryptochidism Serum Bisphenol A Free serum BPA level in cryptorchid boys and in the control
group was not statistically signiﬁcant but the conjugated and
total serumBPA level was elevated in cryptorchid boys
3 1
aCR: completeness of reporting on a scale from 0 (low completeness) to 11 (high completeness).
bBias and confounding: 1 = higher risk of bias, 0 = lower risk of bias.
112
Bonde
etal.
Downloaded from https://academic.oup.com/humupd/article-abstract/23/1/104/2605945
by Kobenhavns Universitets user
on 11 January 2018
(3) Selection bias due to attrition in follow-up studies and non-response
in case-referent studies: Attrition/non-response >20% or attrition/
non-response differing by >10% in exposed/cases and unexposed/
referents was considered as a potential cause of bias in an unpredict-
able direction.
(4) Information bias (outcome ascertainment): Outcomes identiﬁed by
patient recall in questionnaires, by interview or medical examination
not blinded towards exposure status is a likely cause of inﬂated risk
estimates because of differential exposure misclassiﬁcation.
(5) Confounding: Failure to account by study design or analysis for major
potentially confounding factors including maternal age, parity, prema-
turity, social class and ethnicity was considered as high risk of bias in
unpredictable directions. Other potentially confounding factors were
considered on an outcome speciﬁc basis: Cryptorchidism is a strong
risk factor for testis cancer and low sperm count, sexual abstinence
and maternal smoking during pregnancy is related to sperm count
and the sons age is related to risk of testis cancer. Weak and/or
uncertain risk factors such as paternal age, maternal consumption of
coffee and alcoholic beverages, infections, malformed uterus and
poorly controlled diabetes were not considered.
(6) Measuring of confounding factors: Potential bias in an unpredictable
direction was considered if measures of confounding factors were
invalid or inadequate.
(7) Exposure contrast: Studies contrasting exposure levels by the median
split rather than by at least exposure-tertiles were considered at risk
of bias towards the null because of insufﬁcient exposure contrast.
We considered selective reporting related to multiple testing (1),
selection bias (3), information bias related to outcome ascertainment (4)
and failure to account for major confounding factors (5) as the most
important threats to validity. Accordingly, we categorized a study as at
higher risk of bias if two or more of these sources of bias were present.
Risk of bias across studies was evaluated by means of funnel plots to
assess risk of publication bias.
Meta-analysis
We applied a stepwise approach addressing four different scenarios for
the association between chemical exposure and included outcomes with
increasing level of speciﬁcity. Only cryptorchidism, hypospadias and tes-
ticular cancer were included in Steps (1)–(4) below, as none of the four
papers addressing sperm count provided risk estimates. The following
associations were analysed:
(1) The association between all types of endocrine disrupting chemicals
with all outcomes assuming that effects occur regardless of speciﬁc
mechanisms and that the four outcomes are manifestations of the
same underlying condition (testicular dysgenesis syndrome;
Skakkebaek, 2002). This analysis assumes that all types of examined
individual compounds are proxies for mixtures of substances that car-
ry the same risk for the adverse reproductive outcomes. This
assumption is very unlikely to be true, but the analysis is informative
when considering global statements on the impact of endocrine dis-
ruptors that do not single out individual substances or mixtures of
particular concern (Bergman et al., 2013).
(2) The associations between speciﬁc chemicals and all outcomes.
Hereby, we account for different endocrine disrupting actions and
potencies exhibited by different compounds and address the tes-
ticular dysgenesis hypothesis stating that all male reproductive out-
comes at least partly are manifestations of the same underlying
causal agents operating in early life (Skakkebaek et al., 2001;
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Skakkebaek, 2003, 2004). One study reported multiple PCB and
PBDE congener speciﬁc risk estimates but no summary estimate
(Carmichael et al., 2010). For this study, we selected the PCB-153
and PBDE-100 as indicators of the total exposure to these com-
pounds and did not include the other congener speciﬁc estimates
(12 estimates). Another study reported the p,p′-DDE exposure
estimate as well as an estimate for the sum of HCB and p,p′-DDE
but no separate estimate for HCB (too few cases). In this case, we
used the sum of the p,p′-DDE and HCB estimate (Giannandrea
et al., 2011).
(3) The associations between all exposures and speciﬁc out-
comes, assuming that endocrine disrupting chemicals in
general carry a risk for some but not other male reproductive
disorders.
(4) Each of the three outcomes individually in relation to speciﬁc com-
pounds or group of compounds under the assumption of speciﬁc
mechanisms and speciﬁc outcomes, but without an a priori ranking of
more or less likely speciﬁc hypotheses. These exploratory analyses
have a narrow scope because data are limited. We only included
exposure–outcome estimates in the meta-analysis if four or more
risk estimates were available.
In sensitivity analyses, we: (i) regrouped compounds into persistent or
rapidly metabolised substances with half-lives in the range of hours; (ii)
excluded studies with blood sampling after the diagnosis of testicular can-
cer; (iii) examined the effect of each study on the overall estimate by
excluding the studies one at a time; (iv) performed separate analyses of
studies with high completeness of reporting and lower risk of bias and
confounding as deﬁned above; and (v) performed separate analyses of
large case-referent studies with at least 75 cases.
We computed a common risk estimate across studies by weighing
the risk ratio (RR) or equivalent (OR or HR) by the inverse variance
computed from the mean of the provided conﬁdence limits. This is justi-
ﬁed because the outcomes are rare (prevalence <5%). Random effects
estimates are presented regardless of tests for heterogeneity since all
studies are conceptually heterogeneous. Nevertheless we also provide
I2 statistics as a formal measure of heterogeneity. Bootstrapping techni-
ques were used in analyses where the same study yielded more than
one risk estimate, to account for multiple risk estimates per person in
studies where risk estimates were reported for several compounds or
outcomes. Bootstrapping with 500 repeats was applied by sampling
among all included risk estimates, ensuring that each study only contrib-
uted one risk estimate to each bootstrapping step. Mean values across
bootstrapped steps were used as overall measures of common risk esti-
mates and conﬁdence limits. These analyses were repeated for each
outcome to account for heterogeneity in the exposure–outcome
relation.
All statistical analyses were performed using R and a signiﬁcance level
of 0.05. We also used this software to create funnel plots of the standard
error by the logarithm of the RR separately for each of the exposures
and for the higher quality studies, and inspected these plots for evidence
of publication bias.
.............................................................................................................................................................................................
Table VII ORs (95% CIs) of the summary estimate of analyses for associations between endocrine disrupting chemicals
and cryptorchidism, hypospadias and testicular cancer. Strata with three or less risk estimates not eligible for meta-
analysis. I2 only available for meta-analyses without bootstrapping (one risk estimate per study).
Exposures Outcomes N studies N risk estimates
(min-max per study)
OR 95% CI I2
All exposures All outcomes 19 70 (1–10) 1.11 0.91–1.35
Cryptorchidism 6 16 (1–7) 1.03 0.72–1.47
Hypospadias 7 18 (1–4) 1.13 0.86–1.50
Testicular cancer 6 36 (2–10) 1.20 0.78–1.89
Bias less likely All outcomes 5 22 (2–7) 1.12 0.81–1.57
Large studies All outcomes 9 34 (1–7) 1.06 0.85–1.33
Excluding studies c. testis studies with adult exposure data All outcomes 13 34 (1–7) 1.07 0.87–1.32
+ Biopersistence All outcomes 17 66 (1–10) 1.15 0.92–1.44
− Biopersistence All outcomes 3 4 (1–2) 1.12 0.71–1.77
DDE All outcomes 13 13 (1) 1.35 1.04–1.74 31.91
Cryptorchidism 3 3 (1)
Hypospadias 4 4 (1) 1.38 0.93–2.04 0.00
Testicular cancer 6 6 (1) 1.19 0.60–2.36 78.05
DDT All outcomes 6 6 (1) 1.07 0.81–1.42 0.00
Cryptorchidism 1 1 (1)
Hypospadias 1 1 (1)
Testicular cancer 4 4 (1) 1.12 0.82–1.55 0.00
PCB All outcomes 9 9 (1) 1.26 0.82–1.96 62.41
Cryptorchidism 2 2 (1)
Hypospadias 4 4 (1) 1.11 0.61–2.01 54.45
Testicular cancer 3 3 (1)
HCB All outcomes 7 7 (1) 1.19 0.87–1.62 40.94
Cryptorchidism 1 1 (1)
Hypospadias 3 3 (1)
Testicular cancer 3 3 (1)
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Results
The study base
We identiﬁed 33 papers that were based upon 28 independent stud-
ies reported 89 associations between measured levels of endocrine
disrupting chemicals and one or more of the outcomes: cryptorchid-
ism (Hosie et al., 2000; Longnecker et al., 2002; Pierik et al., 2004,
2007; Bhatia et al., 2005; Damgaard et al., 2006; Main et al., 2007;
Brucker-Davis et al., 2008; McGlynn et al., 2009a; Fenichel et al.,
2012; Chevalier et al., 2015; Jensen et al., 2015; Komarowska et al.,
2015; Small et al., 2009; Trabert et al., 2012; Vesterholm et al., 2014;
Toft et al., 2016; Virtanen et al., 2012); hypospadias (Longnecker
et al., 2002; Bhatia et al., 2005; Small et al., 2009; McGlynn et al.,
2009a; Carmichael et al., 2010; Giordano et al., 2010; Choi et al.,
2012; Jensen et al., 2015; Rignell-Hydbom et al., 2012; Trabert et al.,
2012; Toft et al., 2016); testicular cancer (Hardell et al., 2003, 2004;
Biggs et al., 2008; Cohn et al., 2010; Giannandrea et al., 2011;
McGlynn et al., 2008; 2009b; Purdue et al., 2009); and sperm count
(Mocarelli et al., 2011; Axelsson et al., 2015; Vested et al., 2013,
2014).
There were 12 papers, based upon nine different study popula-
tions, which compared exposure levels in cases and referents but did
not provide risk estimates. An overview of eligible studies and risk
estimates are given in Tables II–IV while the results of three studies
(four papers) addressing sperm count and six studies (eight papers)
addressing cryptorchidism and hypospadias without risk estimates are
displayed in Tables V and VI. Most studies addressed persistent orga-
nochlorines such as DDE, the metabolite of DDT (18 associations),
PCBs (12 associations), DDT and HCB (each 12 associations), while
studies on rapidly metabolized compounds such as phthalate ethers
and Bisphenol were sparse. The systematic literature search seems
to have been efﬁcient since no additional papers fulﬁlling the eligibility
criteria were identiﬁed from hand searches of reference lists or
reviews. The majority of the studies were case-referent studies, many
nested within large well-deﬁned cohorts, while two studies of sperm
count were cohort studies (Vested et al., 2013, 2014) and two were
cross-sectional studies (Mocarelli et al., 2011; Axelsson et al., 2015).
Records identified through database
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S
cr
ee
n
in
g
In
cl
u
d
ed
E
li
g
ib
il
it
y
Id
en
ti
fic
at
io
n
Records identified through hand
searches (n = 0)
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(n = 110)
Full-text articles excluded,
with reasons
(n = 77)
Papersincluded in
qualitative synthesis
(n = 33)
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quantitative synthesis
(meta-analysis)
(n = 21)
Figure 1 Flow diagram showing results of a systematic literature search to identify peer review papers addressing risk of male reproductive disor-
ders following prenatal and infancy exposure to environmental endocrine disrupting compounds.
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The case-referent studies included a total of 2446 cases of which 671
cases were cryptorchidism, 570 cases were hypospadias and 1205
cases were testicular cancer. In addition 324 men took part in studies
of semen quality. Of all of the studies, 19 were published within the
past 10 years, of these 13 were carried out in the United States of
America or Scandinavia. The completeness of reporting assessed by
11 items were considered high (sum score ≥8 of 11 items) for over
65% of the papers. But less than half of the studies were considered
at low risk of bias and confounding. Only ﬁve case-referent studies
included >75 cases. Using the form in Supplementary Table 3, we
extracted detailed information on each study and including our evalu-
ation of completeness of reporting and potential biases (data available
on request). In the following sections, we ﬁrst present the results of
the quantitative meta-analysis and next we review papers that did
not report risk estimates.
Global assessment: generic exposures and
outcomes as one entity (Hypothesis 1)
The meta-analysis, including all 70 eligible estimates addressing the
risk for cryptorchidism, hypospadias or testicular cancer and giving
equal weight to each of the xenobiotic exposure indicators, showed
an overall risk estimate marginally above unity with rather narrow
95% conﬁdence limits including unity, OR 1.11 (95% CI 0.91–1.35)
(Table VII), and the estimate was similar in studies less likely to be
biased, OR 1.12 (95% CI 0.81–1.57). A funnel plot revealed some
indication of publication bias as studies with few cases and large
standard errors seemed overrepresented among studies with ele-
vated risk estimates (Fig. 2). In a subsequent analysis excluding studies
with <75 cases, we found an attenuated summary estimate (OR
1.06, 95% CI 0.85–1.33) (Table VII, ‘Large studies’) but with no indi-
cation of publication bias in the corresponding funnel plot (data not
shown). Leaving out ﬁve estimates originating from studies addressing
xenobiotics with rapid metabolism and excretion (phthalates) pro-
duced similar results (Table VII‘+biopersistent/-biopersistent’). No
single study or exposure had a major impact on the summary risk
estimate. Studies addressing p,p-DDT, p,p′-DDE and HCB contribu-
ted the most.
Speciﬁc exposures and outcomes as one
entity (Hypothesis 2)
Data were available for substance speciﬁc analyses of risk of any of the
reproductive disorders for the most frequently examined compounds
(p,p′-DDT, p,p′-DDE, PCB and HCB). Results are summarized in
Table VII. The summary estimate was above unity of all exposures but
only statistically signiﬁcantly elevated for p,p′-DDE (Fig. 3).
Generic exposures and speciﬁc outcomes
(Hypothesis 3)
Cryptorchidism
Ten case-referent studies based upon six study populations provided
16 risk estimates for cryptorchidism (Fig. 4). The most frequently
studied exposures were persistent organochlorine pesticides and
PCBs which were measured in maternal pregnancy or postpartum
blood samples, or cord blood or breast milk, and one study used
Figure 2 Funnel plot of all risk estimates from all studies included in the meta-analysis (n = 70) of the association between prenatal and postnatal
exposure to endocrine disrupting environmental chemicals and male reproductive disorders. Risk estimates with identical colors are derived from
same study.
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amnion ﬂuid to assess exposure to phthalates and perﬂuorooctane
sulfonic acid (PFOS). Among the 16 risk estimates, nine were above
unity and four exceeded a relative risk of 2. The meta-analytic sum-
mary estimate was close to unity, OR 1.03 (95% CI 0.72–1.47),
Fig. 4. Funnel plots did not indicate publication bias (data not shown).
Hypospadias
Nine case-referent studies based upon seven study populations
addressed links between xenobiotics and hypospadias and all studies
except one measured xenobiotics in maternal serum (Fig. 5). Five of
the studies also reported on cryptorchidism. Among 18 risk esti-
mates, 11 were above unity and seven were below and one relative
risk exceeded 2. The summary estimate was close to unity, OR 1.13
(95% CI 0.86–1.50), Table VII. Funnel plots did not indicate publica-
tion bias (data not shown).
Testicular cancer
Eight case-referent studies based upon six study populations examined
risk of testicular cancer according to environmental exposure to poten-
tial endocrine disruptive chemicals (Fig. 6). Two early Swedish studies
measured xenobiotics at the time of diagnosis in the men and in a sub-
set of their mothers at the same time (Hardell et al., 2003, 2006),
while a few later studies targeted the hypothesis of prenatal origins of
testicular cancer assuming that persistent organic pollutants in prediag-
nostic serum samples of young men was a useful proxy of in utero
exposure and early infancy exposure (Biggs et al., 2008; Giannandrea
et al., 2011; McGlynn et al., 2008). Only a single study was based on
maternal serum samples (Cohn et al., 2010). Altogether, the eight
case-referent studies provided 36 risk estimates with DDT being the
most frequently examined compound (seven estimates). Of these, 26
estimates were above unity and nine exceeded a relative risk of 2. The
summary estimate was slightly elevated but not statistically signiﬁcantly
different from one, OR 1.20 (95% CI 0.78–1.89). The funnel plot was
compatible with publication bias since small studies contrary to large
studies reported a non-proportional large number of elevated risk esti-
mates (data not shown).
Sperm count
No risk estimates available.
Speciﬁc exposures and speciﬁc outcomes
(Hypothesis 4)
Available data for speciﬁc exposure and speciﬁc outcomes are lim-
ited. Four or more risk estimates were only available for four expos-
ure–outcome combinations. Results of the conventional meta-
analysis without bootstrapping (since risk estimates are independent)
are shown in Table VII. The summary relative risk estimates were
slightly above unity but none were statistically signiﬁcant.
Figure 3 Forest plot of risk estimates (95% CI) from studies included in the boot strap meta-analysis of the association between prenatal and
postnatal exposure to DDE and cryptorchidism, hypospadias or testicular cancer (N = 13).
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Studies not eligible for meta-analysis
Cryptorchidism
Six case-referent studies based upon four independent study popula-
tions did not provide risk estimates but compared concentrations of
xenobiotics in fat samples, breast milk, placenta tissue, maternal serum
or cord blood in cases and controls (Hosie et al., 2000; Damgaard
et al., 2006; Main et al., 2007; Fenichel et al., 2012; Komarowska et al.,
2015; Virtanen et al., 2012), Table V. Altogether these papers report
104 exposure–outcome comparisons, ignoring that some studies
Figure 5 Forest plot of risk estimates (95% CI) from studies included in the boot strap meta-analysis of the association between prenatal and
postnatal exposure to endocrine disrupting environmental chemicals and hypospadias (n = 18).
Figure 4 Forest plot of the risk estimates from studies included in the meta-analysis of the association between prenatal and postnatal exposure
to endocrine disrupting environmental chemicals and cryptorchidism (n = 16).
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examined compounds in more than one type of biological medium.
The ﬁndings with respect to biopersistent organochlorines results are
largely consistent with the ﬁndings in the quantitative meta-analysis,
showing limited evidence of associations. This also applies to studies
with high completeness of reporting and less likely risk of bias, that
addressed PBDE, TCDD, PCDD and organochlorine pesticides
(Table V). Bootstrapping analyses of the subset of the seven substances
with highest breast milk concentrations indicated higher median values
in cases but this may be a chance ﬁnding since the overall analysis of all
compounds was non-signiﬁcant (Damgaard et al., 2006). The study on
brominated ﬂame retardants found increased levels in breast milk sam-
ples among cases, but this result was not conﬁrmed in analyses based
upon corresponding placenta tissue samples, which a priori were
thought to provide the most accurate measure of fetal exposure (Main
et al., 2007). Findings in other studies mainly addressing rapidly meta-
bolized contaminants were also reassuring, but these studies were con-
sidered at high risk of bias (Table V).
Hypospadias
Two studies, not providing best practice reporting and considered at
higher risk of bias, did not provide risk estimates but compared con-
centrations of xenobiotics in blood and urine samples in cases and con-
trols (Shekharyadav et al., 2011; Choi et al., 2012; Table V). In the ﬁrst
study, compounds with short biological half-lives were examined and
three out of eight substances were elevated in serum samples com-
pared to controls but these results were not entirely consistent with
results based upon urine samples (Choi et al., 2012). The other study
examined nine biopersistent pesticides and observed higher concentra-
tions in serum from cases for them all (Shekharyadav et al., 2011).
Sperm count
To date only three studies (four papers) explicitly studying xenobiotic
prenatal exposure to potential endocrine disrupting compounds rela-
tive to semen quality in adult men have been published (Table VI).
These studies are highly heterogeneous with respect to design and
xenobiotics and a meta-analysis is not appropriate. Rather than pro-
viding risk estimates for reduced sperm count these studies report
measures of average sperm counts according to the level of xeno-
biotic. Sons of women living near a chemical plant exposed to dioxin
due to an accident in 1976 that contaminated the surroundings were
identiﬁed in a seminal study and serum dioxin concentration at the
time of conception during the period 1977–1984 was estimated
based upon bio-banked maternal serum samples. Sperm counts in
the exposed group of sons were compared with counts from men
with assumed background exposure. Average sperm counts were
almost halved in the exposed group and the effect was most pro-
nounced among men who had been breastfed during childhood
(Mocarelli et al., 2011). The sample included only 39 exposed men
Figure 6 Forest plot of risk estimates (95% CI) from studies included in the boot strap meta-analysis of the association between exposure to
endocrine disrupting environmental chemicals and testicular cancer (n = 36).
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and was too small to allow for exposure-response analysis. In a
Danish study, sons of mothers with biobanked serum samples pro-
vided semen samples when they were 19–21 years of age and sperm
count was examined according to tertiles of maternal serum concen-
tration of a range of compounds. There was no indication that PCBs,
the DDT metabolite DDE or PFOS were associated with reduced
sperm count, but high level PFOA exposure was signiﬁcantly asso-
ciated with reduced sperm concentration (Vested et al., 2013, 2014).
Finally, a Swedish cross-sectional study using biobanked maternal ser-
um samples did not show associations between sperm count and a
range of phthalate metabolites (Axelsson et al., 2015).
Discussion
This is the ﬁrst systematic review with meta-analysis that has rigorously
evaluated the epidemiological evidence on prenatal and postnatal
exposure to endocrine disrupting compounds and male reproductive
disorders. A total of 33 papers provided 89 risk estimates on which
we found no strong support for a global effect as a whole or on any
speciﬁc outcome. However, one of four speciﬁc compounds with sufﬁ-
cient data to allow for meta-analysis were related to a moderate
increased risk of all outcomes taken together (p,p′-DDE). Although
only limited data were available for speciﬁc exposure–outcome associa-
tions, these ﬁndings do not seem to be due to increased risk of any sin-
gle included disorder (cryptorchidism, hypospadias or testicular
cancer). Thus ﬁndings provide some support to the hypothesis of
shared prenatal etiology of these outcomes, but they also point to het-
erogeneity of compounds classiﬁed as endocrine disruptors with
respect to potential effects on male reproduction.
The strength of this review in comparison with narrative reviews
and global assessments is primarily that it includes, to our knowledge,
all published epidemiological evidence fulﬁlling predeﬁned criteria
using a systematic and transparent search of the literature. Although
the ﬁndings of this review provide some evidence for environmental
endocrine disruption of male reproductive function, the limitations of
observational epidemiology and the outcomes reported in the few
available high quality studies precludes strong concluding statements.
Exposure assessment
Reliable exposure assessment is essential in environmental epidemi-
ology and measurements of the compounds of interest are consid-
ered as the gold standard. We therefore only included studies with
actual measurements of the chemicals in tissues as exposure assess-
ment based on external determinants (such as job title) is crude
when it comes to endocrine disrupting chemicals. Analyses of blood
or tissue concentrations of chemicals were performed by gas chro-
matography/mass spectrometry and most studies provided data on
recovery and between batch coefﬁcients of variation. Although differ-
ences in sample preparation, analytical technique and units may invali-
date comparisons of absolute exposure levels across studies, this is
not expected to affect risk estimates that are derived from within-
study contrasts of exposure levels.
Misclassiﬁcation of exposure at the susceptible periods of devel-
opment most likely results in bias towards the null. Most studies
measured the contaminants late in pregnancy, at birth or during
lactation and not precisely at the time of differentiation of the male
gonads, that based upon animal studies in the rat, is assumed to
take place in gestational week 8–14 (Welsh et al., 2008; Macleod
et al., 2010). Considering the long half-lives of the persistent chemi-
cals with little expected ﬂuctuation of tissue levels across a few
months, measurements around the time of birth seems a reason-
able proxy for exposure levels during early pregnancy although dis-
tribution kinetics during pregnancy may be an issue (Verner et al.,
2013). This is entirely different for compounds with a rapid metab-
olism and excretion such as phthalates and bisphenol A, which ﬂuc-
tuate markedly within individuals as shown in studies with repeated
sampling. Thus, in a study where three blood samples were taken
during pregnancy the intra-class coefﬁcient of variation were for
most phthalate metabolites between 20% and 40% (Cantonwine
et al., 2014). However, at the group level serum levels of metabo-
lites were remarkably stable. The direction of bias may be in either
direction in the individual study but tends, on average, to cause bias
towards null. One of the included studies measuring phthalate
metabolites in amnion ﬂuid in the second trimester found no associ-
ation with cryptorchidism and hypospadias even though one DEHP
metabolite was related to higher fetal testosterone and lower
insulin-like factor III (Jensen et al., 2015).
Assessment of fetal exposure using maternal blood or milk samples
assumes that the placenta is not an efﬁcient barrier for chemical
transfer from the maternal to the fetal circulation and that fetal
exposure is proportional to maternal exposure. It is therefore note-
worthy that knowledge regarding the transport of persistent xenobio-
tics over the placenta to the fetus has been known for decades
(Needham et al., 1999; Mazdai et al., 2003). More recent ﬁndings
indicate that rapidly metabolized compounds also pass through the
placenta and these have been detected in cord blood and amnion
ﬂuid (Jensen et al., 2015).
Exposure contrast within and across studies
The most prevalent persistent organochlorine contaminants were
banned in high income countries during the 1970s and subsequently
their tissue levels have declined substantially. However, the studies
included in this review encompass studies based upon samples bio-
banked >50 years ago such as the Collaborative Perinatal Study with
relatively high serum concentrations (Longnecker et al., 2002; Pierik
et al., 2007; McGlynn et al., 2008, 2009b; Trabert et al., 2012) as well
as studies based upon sampling much later (Damgaard et al., 2006;
Main et al., 2007; Virtanen et al., 2012). Unfortunately, data are too
sparse to allow for a formal meta-analysis based upon the variation in
exposure levels in reference populations throughout time; however,
no individual studies with large exposure contrast found evidence for
a relationship between exposure and response.
Since this review is focused upon prenatal exposures, we
excluded a wealth of cross-sectional studies linking occupational and
environmental exposure in adulthood with semen quality (for a
recent review and a large collaborate study summary, see Bonde
et al., 2008; Bonde and Giwercman, 2014). In contrast to testicular
cancer, it is well established that spermatogenesis is susceptible to
short-term effects of reproductive toxicants not least in the
workplace.
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Outcome ascertainment
The male reproductive disorders addressed in this review are distinct
diseases with different pathologies, clinical characteristics and age of
appearance. Cryptorchidism and hypospadias were either deﬁned by
speciﬁed criteria applied in systematic examinations of newborns in
prospective studies or from medical records. Although criteria for
both disorders may differ substantially and contribute to apparent
secular trends and spatial shifts in prevalence rates, it is unlikely that
differences in outcome ascertainment across studies disrupt the
internal validity and the relative risk estimates. No studies used par-
ticipant questionnaires or interviews to deﬁne outcomes and there-
fore recall bias is not an issue in studies included in this review.
The testicular dysgenesis syndrome
hypothesis
We analyzed the male reproductive disorders, with the exception of
low sperm count where no risk estimates were available, as one
entity with reference to the testicular dysgenesis syndrome hypoth-
esis on shared etiology of the four male reproductive disorders
(Skakkebaek, 2002) and with reference to experimental evidence sug-
gesting multiple mechanistic pathways of endocrine disruption
(Toppari, 2002). The strength of the testicular dysgenesis syndrome
hypothesis and the applicability of this concept as explanation of the
pathogenesis of the majority of its components is an important pre-
requisite for obtaining statistically signiﬁcant associations when testing
hypotheses I and II, where cryptorchidism, hypospadias and testicular
cancer were merged together as end points in statistical analyses.
However, the heterogeneity of the pathogenesis underlying those
conditions and their relative weak or moderate mutual clinical asso-
ciations might indicate that only a minor proportion of these male
reproductive abnormalities ﬁt into the testicular dysgenesis syndrome
concept (Thorup et al., 2010), which may explain the generally non-
signiﬁcant or only weakly statistically signiﬁcant ﬁndings of our
analyses.
Studies addressing testicular cancer
Although focus was on developmental disorders induced by chemical
exposure during critical time windows in early life (Lee and Jacobs,
2015), there only exists one small study using prenatal or postnatal
bio-specimens to assess testicular cancer (Cohn et al., 2010). We
therefore included six studies on testicular cancer assessing exposure
by measurement of chemicals in serum samples obtained after
puberty. Hereby, we assume that serum levels of persistent chemicals
in young men or their mothers are reasonable proxies for prenatal
and postnatal exposure. There is however some evidence to support
this strong assumption. First of all, the biological half-lives of many of
these compounds are counted in decades (Hagmar et al., 2006).
Moreover, studies in a Faroese birth cohort demonstrated strong
intra-individual correlations between persistent chemicals in cord
blood and serum concentrations at 7 and 14 years of age, respect-
ively (Barr et al., 2006). Another study found high correlations of per-
sistent chemical levels in serum samples in adult men obtained up to
10 years apart (Hagmar et al., 2006). Finally, a history of breastfeed-
ing was related to elevated serum levels in men up to 40 years later
in one study (Biggs et al., 2008). Although adult serum concentrations
of persistent chemicals may to some extent reﬂect prenatal and early
postnatal exposure, it is obvious that varying rates of metabolism as
well as additional lifetime exposures during infancy, childhood and
adulthood also contribute to exposure levels. The resulting misclassi-
ﬁcation most is most likely is towards the null. Accordingly it is not
surprising that the overall risk estimate was attenuated in the analysis
excluding studies on testis cancer with adult serum data only.
Studies addressing sperm count
Although the effects of endocrine disrupting chemicals on male fertil-
ity has been the focus of heated debate (Bonde et al., 2011), only
three human studies have to date linked prenatal and postnatal
exposure to xenobiotics with sperm count in adults (Mocarelli et al.,
2011; Axelsson et al., 2015; Vested et al., 2013). This is probably
explained by the difﬁcult and costly logistics of population-based
semen studies and the need for maternal biospecimens or cord blood
stored decades before follow-up takes place. In the study by
Mocarelli et al., the ﬁndings of halved sperm counts in men whose
mothers were exposed to higher levels of dioxin when pregnant are
intriguing but call for cautious interpretation. Exposure levels in
women living in the contaminated area are overlapping the back-
ground exposure, participants are few, referents are from a conveni-
ence sample and signiﬁcant results were limited to the subgroup of
men breast-fed as infants (Mocarelli et al., 2011). The pertinent ques-
tion is whether sperm counts in the exposed group are low (in the
range of 45 mill/mL) or whether sperm counts in the reference
group are high (in the range of 80 mill/mL). It is well established that
small cross-sectional semen studies are highly vulnerable to selection
bias (Larsen et al., 1998). Unfortunately it is hardly possible to repli-
cate the ﬁndings. Results from the sole study that was explicitly
designed to test the hypothesis on delayed effects on sperm count
are reassuring with respect to organochlorines (Vested et al., 2014),
but less so with respect to the much less studied but ubiquitous per-
ﬂuorinated hydrocarbons (Vested et al., 2013). The Swedish study
addressing phthalate metabolites did not reveal adverse effects but
exposure assessment of the rapidly metabolized compounds with
high within-day and between-days variation within individuals is an
issue. Nevertheless single spot urine samples may distinguish different
exposure levels at the population level if study populations are sufﬁ-
ciently large (Hagmar et al., 2006; Preau et al., 2010; Ye et al., 2011).
Obviously there is a need to design future studies with sufﬁcient
power to examine exposure–response associations. With the aging
large European birth cohorts with stored maternal serum samples,
this will become feasible in a few years.
Methodological issues
Many of the included studies examined several compounds for which
risk estimates are not independent. This was accounted for by the
use of bootstrapping statistical techniques by which analyses are iter-
ated several hundred times randomly including only one risk estimate
per population in each analysis and providing an average risk estimate
giving equal weight to studies with few and many risk estimates. This
method does not provide statistics for heterogeneity which is consid-
ered less of a problem since study populations and risk estimates
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obviously are heterogeneous. Therefore, we used random effects
models rather than ﬁxed effects models in all analyses. In spite of
strong heterogeneity across studies with respect to study popula-
tions, exposures and outcomes, it is remarkable that all summary risk
estimates from substance and outcome speciﬁc supplementary ana-
lyses are of similar magnitude spanning a relative risk from 1.03 to
1.26 when ignoring one outlying observation.
The number of studies addressing speciﬁc chemicals and outcomes
were few and did not permit robust meta-analysis. Therefore, this
review is primarily informative with respect to the overall association
and the hypothesis on shared etiology. A number of studies did not
report risk estimates but used other measures of associations.
However, those ﬁndings did not seem to deviate from the overall
picture.
Since we only included studies that documented exposure by
objective analysis of compounds in biological media, the often
encountered risk of bias due to differential recall of exposure or out-
come was bypassed. Selection bias related to prior knowledge about
levels of contaminants in biological tissues among patients or
researchers therefore also seems unlikely. Few, if any, know their
own tissue concentrations of the investigated contaminants to which
all persons are exposed. Moreover, the nested case-referent design
adopted by the majority of the included studies promotes compar-
ability of cases and referents with respect to social and behavioral
factors that may be related to exposure levels and thus indirectly
cause bias. The two main reasons for rating some studies at a higher
risk of confounding was either due to lack of or insufﬁcient adjust-
ment for potential confounding factors such as maternal age and pre-
maturity in case of congenital malformations with unpredictable
direction of bias or small study size that was not justiﬁed by power
calculations which may increase the risk of publication bias. In fact
funnel plots indicated overrepresentation of higher risk estimates in
small studies with larger standard errors. Selective reporting did not
appear to be a problem. All studies seemed to provide data on all
measured substances regardless of association. Finally, only a few
studies corrected for weight gain during pregnancy which may cause
false positive associations due to dilution of the distribution volume
for biopersistent chemicals (Verner et al., 2013), an issue if the out-
come is related to lower birthweight or congenital malformations.
Nevertheless, the ﬁndings must be interpreted in the light of the
complexity of this research ﬁeld. Thus, the meta-analyses strongly
violates basic assumptions in that populations, chemical substances
and outcomes differ across studies (Rothman and Greenland, 1998),
which necessarily must result in substantial heterogeneity disregarding
results of any statistical test. The meta-analytic summary estimates
and their conﬁdence limits are not quantitatively reliable measures of
speciﬁc exposure–outcome relations but merely serve to provide an
overview of the available limited evidence.
Cocktail effects
Humans are simultaneously exposed to a plethora of hundreds of
xenobiotics. Some in vitro and in vivo animal studies have demon-
strated combined effects of endocrine disrupting chemicals at levels
at which the individual chemicals do not induce observable effects
(Kortenkamp, 2007; Kortenkamp, 2014). Because of this ‘cocktail
effect’ of mixtures, scientist have criticized epidemiological studies for
most often addressing effects of individual chemicals one by one.
However, this criticism ignores to some extent that persistent organic
pollutants are highly correlated and epidemiological studies addres-
sing one indicator chemical, for example PCB-153, are in fact reﬂect-
ing exposure to a mixture of numerous other chemicals. For
example, in a study of persistent organic pollutants and fertility, it was
not possible to distinguish between the potential effects of PCBs and
the DDT metabolite DDE (Axmon et al., 2006).
Non-monotonic dose–response relationships
Another concern is the possibility of non-monotonic dose–response
relationships which may explain apparently inconsistent ﬁndings
across studies because of different levels and ranges of exposures
(Vandenberg et al., 2012). This is particularly a potential problem
when extrapolating from high occupational exposure levels to low
environmental levels and in risk assessment with a need to extrapo-
late from high doses in in vitro and in vivo animal studies to many-fold
lower environmental levels that humans encounter. However, the
possibility of non-monotonic dose–response relationship is less of a
problem in large population-based studies capturing a broad low-
level exposure range (Lee and Jacobs, 2015). None of the large stud-
ies included in this review with substantial exposure contrast and
comprehensive evaluation of risk according to exposure strata indi-
cate the existence of such non-monotonic exposure–response rela-
tionships (Longnecker et al., 1997, 2002).
Wider implications and conclusion
The widely stated view that ubiquitous endocrine disrupting chemi-
cals in our environment play a substantial role in the development of
male reproductive disorders through prenatal and perinatal mechan-
isms is to some extent challenged by this review. Although the cur-
rent epidemiological evidence is compatible with a small increased
risk of male reproductive disorders following prenatal and postnatal
exposure to some persistent environmental chemicals classiﬁed as
endocrine disruptors, the evidence is limited. In this light, estimates
of the burden of disease and costs of exposure to endocrine chemi-
cals (Trasande et al., 2016) seem highly speculative, at least with
respect to male reproductive disorders. Future epidemiological stud-
ies may change the weight of the evidence in either direction and the
need for appropriate risk assessment of chemicals based upon
experimental evidence should not be ignored. There are insufﬁcient
data on rapidly metabolized endocrine disruptors and speciﬁc expos-
ure–outcome relations. A particular data gap is evident with respect
to delayed effects on semen quality and testicular cancer.
Supplementary data
Supplementary data are available at http://humupd.oxfordjournals.
org/.
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